DNV GL Healthcare Creates New Hospital Requirement for Antimicrobial Stewardship
DNV GL Healthcare recently updated their NIAHO Hospital Accreditation Requirements, effective January 21, 2019. DNV GL Healthcare has created a new Medication Management requirement to reflect their commitment to the U.S. Centers for Disease Control and Prevention (CDC) Antimicrobial Resistance (AMR) Challenge, to comply with accepted standards of practice and to align with U.S. Centers for Medicare and Medicaid Services requirements.
Medication Management requirement (MM.8) requires hospitals to have a program in place to enhance antimicrobial stewardship, including the appropriate selection, dosing, route, and duration of antimicrobial therapy.
In order to comply with the requirements under MM.8, hospitals should develop and implement policies and procedures related to core elements of the antimicrobial stewardship program, including but not limited to:
- Establishing an antimicrobial stewardship team that has multidisciplinary representation (including clinicians, department heads, infection preventionists, hospital epidemiologists, quality improvement staff, laboratory staff, information technology staff, nursing, and pharmacy staff)
- Ensuring that the necessary human, financial and information technology resources to support an antimicrobial program are available.
- Appointing a single leader responsible for the organization’s antimicrobial program.
- Ensuring that the organization has a single pharmacist leader responsible for working to improve antibiotic use.
- Implementation of specific actions to impact antibiotic use (e.g., “antibiotic time out” after 48 hours).
- Monitoring antibiotic prescribing and resistance patterns.
- Regular communication to stakeholders on antibiotic use and resistance.
Included with today’s notice are example policies related to an antimicrobial stewardship program. Also included is a link to the updated NIAHO Hospital requirements.
Want to read the full alert and receive alert emails?